J. Westermann et al., RETROVIRAL INTERLEUKIN-7 GENE-TRANSFER INTO HUMAN DENDRITIC CELLS ENHANCES T-CELL ACTIVATION, Gene therapy, 5(2), 1998, pp. 264-271
Citations number
47
Categorie Soggetti
Biothechnology & Applied Migrobiology","Genetics & Heredity",Biology,"Medicine, Research & Experimental
Tumor vaccination with dendritic cells (DC) presenting tumor antigens
to T cells is a promising approach in immunotherapy. the aim of this s
tudy was to enhance T cell stimulatory ability of human DC by retrovir
al expression of the interleukin-7 (IL-7) gene. IL-7 has been shown to
provide a potent costimulatory signal for the proliferation of T cell
s and the generation of cytotoxic T cells (CTL). DC were generated fro
m human peripheral blood mononuclear cells (PBMC). DC were analyzed by
light- and electron-microscopy, immunophenotype (CD1a(+), CD14(-), CD
80(+), CD86, HLA-DR+) and functional assays. According to these criter
ia, 75-85% of the cells were DC. The cells did not produce measurable
amounts of IL-7 spontaneously nor did they express the IL-7 receptor.
A retroviral IL-7 expression vector was constructed. Retroviral infect
ion was performed with either the LXSN-hIL-7 vector or its variant LXS
N. Using the LXSN-hIL-7 vector, IL-7 production of 2296 pg/10(6) cells
/24 h could be achieved on average. Transduction of DC was confirmed b
y RT-PCR in a CD1a-enriched cell fraction. Transduction efficiency by
a control virus coding for beta-galactosidase was about 30%. In autolo
gous mixed lymphocyte reaction (MLR), IL-7 transduced DC augmented T c
ell proliferation by a factor of two compared with unmodified or mock-
transfected DC, and in allogeneic MLR there was a 2.7-fold increase in
T cell proliferation. The increase in T cell proliferation could be c
orrelated to IL-7 secretion by DC. Dendritic cells that have been simu
ltaneously peptide-loaded and gene-modified to secrete IL-7 are a pote
ntial tool to amplify activation of tumor-specific T cells.